Pragavis-NM Tablet SR
Marketer
Vistran Pharmaceuticals
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Pragavis-NM Tablet SR
Neuropathic pain relief is provided by the extended-release Pragavis-NM Tablet SR, a multi-component medication. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain signals. Concurrently, it elevates brain neurotransmitters, improving mood regulation and nerve fiber protection. Pragavis-NM Tablet SR can be administered with or without food, but consistent daily timing ensures stable drug levels. Adhere strictly to your physician's prescribed dosage and duration. Missed doses should be taken immediately upon recall. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is strongly discouraged due to potential symptom exacerbation. Common side effects include constipation, weight increase, and dry mouth. Dizziness and drowsiness may occur; avoid driving or tasks requiring alertness until the medication's effects are known. Weight gain may necessitate a balanced diet and regular exercise. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all other medications, as interactions can affect efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Pragavis-NM Tablet SR
Managing neuropathic pain
Major Benefits of Pragavis-NM Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pragavis-NM Tablet SR can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Pragavis-NM Tablet SR:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Pragavis-NM Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pragavis-NM Tablet SR can be administered with or without food, however, consistent timing is recommended.
How Pragavis-NM Tablet SR works:
Pragavis-NM SR tablets contain pregabalin, nortriptyline, and methylcobalamin, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain transmission by modulating nerve cell activity. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal transmission in the brain. Methylcobalamin, a B vitamin, supports myelin sheath production and repair, protecting and restoring damaged nerve fibers. This combined action provides effective neuropathic pain relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pragavis-NM SR tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Pragavis-NM SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Pragavis-NM tablets pose a likely risk during lactation. Available human data indicate potential drug transfer to breast milk, with the possibility of infant harm.
DrivingUNSAFE
Driving ability may be impaired by Pragavis-NM Tablet SR due to potential side effects that can reduce alertness.
KidneyCAUTION
Exercise caution when prescribing Pragavis-NM Tablet SR to individuals with impaired renal function. Dosage modification of Pragavis-NM Tablet SR may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pragavis-NM Tablet SR in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Pragavis-NM Tablet SR :
Should you forget a Pragavis-NM Tablet SR dose, ingest it immediately if feasible. However, if your next scheduled dose is imminent, omit the missed dose and resume your normal dosing regimen. Avoid taking a double dose.
Facts to Know About Pragavis-NM Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |



